Rafferty Asset Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 64,576 shares of RYTM stock, worth $3.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

64,576

Previous 72,562 11.01%

Holding current value

$3.65 Million

Previous $2.98 Million 13.56%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$40.81 - $55.0 $325,908 - $439,230	-7,986 Reduced 11.01%	64,576 $3.38 Million
Q2 2024 Aug 13, 2024	SELL	$35.41 - $44.37 $5.17 Million - $6.48 Million	-146,095 Reduced 66.81%	72,562 $2.98 Million
Q1 2024 May 13, 2024	BUY	$39.12 - $52.44 $3.79 Million - $5.09 Million	97,003 Added 79.74%	218,657 $9.47 Million
Q4 2023 Feb 13, 2024	SELL	$21.39 - $49.64 $880,198 - $2.04 Million	-41,150 Reduced 25.28%	121,654 $5.59 Million
Q3 2023 Nov 13, 2023	SELL	$15.81 - $27.8 $1.53 Million - $2.68 Million	-96,540 Reduced 37.22%	162,804 $3.73 Million
Q2 2023 Aug 11, 2023	BUY	$16.32 - $21.15 $67,466 - $87,434	4,134 Added 1.62%	259,344 $4.28 Million
Q1 2023 May 11, 2023	SELL	$16.88 - $34.24 $857,554 - $1.74 Million	-50,803 Reduced 16.6%	255,210 $4.55 Million
Q4 2022 Feb 13, 2023	BUY	$22.21 - $30.25 $971,132 - $1.32 Million	43,725 Added 16.67%	306,013 $8.91 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $1.13 Million - $8.09 Million	262,288 New	262,288 $6.43 Million
Q1 2022 May 13, 2022	SELL	$6.13 - $12.24 $684,071 - $1.37 Million	-111,594 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$8.62 - $13.9 $247,738 - $399,486	28,740 Added 34.69%	111,594 $1.11 Million
Q3 2021 Nov 10, 2021	SELL	$11.68 - $20.72 $1,950 - $3,460	-167 Reduced 0.2%	82,854 $1.08 Million
Q2 2021 Aug 10, 2021	SELL	$18.52 - $22.55 $715,723 - $871,467	-38,646 Reduced 31.76%	83,021 $1.63 Million
Q1 2021 May 10, 2021	BUY	$20.25 - $39.49 $2.27 Million - $4.42 Million	111,888 Added 1144.17%	121,667 $2.59 Million
Q4 2020 Feb 10, 2021	SELL	$21.17 - $32.61 $19,095 - $29,414	-902 Reduced 8.44%	9,779 $291,000
Q3 2020 Nov 13, 2020	BUY	$18.13 - $30.61 $193,646 - $326,945	10,681 New	10,681 $231,000
Q1 2020 May 15, 2020	SELL	$13.16 - $22.9 $274,346 - $477,396	-20,847 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$19.53 - $25.5 $139,327 - $181,917	-7,134 Reduced 25.5%	20,847 $479,000
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $200,984 - $264,560	10,794 Added 62.8%	27,981 $604,000
Q2 2019 Aug 09, 2019	BUY	$21.11 - $28.48 $64,828 - $87,462	3,071 Added 21.76%	17,187 $378,000
Q1 2019 May 15, 2019	BUY	$24.76 - $31.66 $349,512 - $446,912	14,116 New	14,116 $387,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.15B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Rhythm Pharmaceuticals, Inc. Transaction History